Paradigm Biocapital Advisors »

Terns Pharmaceuticals shares owned by Paradigm Biocapital Advisors

Quarter-by-quarter ownership of Terns Pharmaceuticals (TERN) shares owned by Paradigm Biocapital Advisors from 13F filings

Historical chart of Paradigm Biocapital Advisors investment in Terns Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Terns Pharmaceuticals held by Paradigm Biocapital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Terns Pharmaceuticals by Paradigm Biocapital Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $33M 810k 40.40